DMD Access Breakthrough and CHMP Pipeline Shift episode artwork

EPISODE · Jun 5, 2026 · 4 MIN

DMD Access Breakthrough and CHMP Pipeline Shift

from Carl Haakon's Podcast

Episode 22 — 05 June 2026 NICE approves third DMD treatment givinostat via Innovative Medicines Fund while CHMP's May output signals structural shift toward rare disease therapies. ISPOR 2026 highlights HEOR's expanding role in policy and value frameworks amid accelerating orphan designation trends. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast

Episode metadata supplied by the publisher feed · Published Jun 5, 2026

Embed this episode

Ready to play

DMD Access Breakthrough and CHMP Pipeline Shift

0:00 4:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Carl Haakon's Podcast?

This episode is 4 minutes long.

When was this Carl Haakon's Podcast episode published?

This episode was published on June 5, 2026.

Can I download this Carl Haakon's Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!